Binxian Wei Net Worth

Binxian Wei biography

Binxian Wei serves as Independent Director of the Company. He has been the V.P. of Darsheng Trade & Tech. Development Co, Ltd. (a subsidiary to Tianjin Tiayo Pharmaceutical Co., Ltd.) since 2015. He is responsible for API and finished dosage marketing for Chinese pharmaceutical companies. From 2008 through 2010, he worked as a business development manager for Sakai Trading. He holds a Master’s degree in Mathematical & Computer Sciences from Colorado School of Mines, a Master’s Degree and Bachelor’s Degree in Chemical Engineering from Tianjin University in China. Bin-Xian Wei was appointed as the director representative of the Series A 4.5% Convertible Preferred Stock by Tianjin Pharmaceuticals Group International Holdings Co., LTD, the sole holder of the outstanding Series A 4.5% Convertible Preferred Stock.

How old is Binxian Wei?

Binxian Wei is 49, he's been the Independent Director of Seneca Biopharma Inc since 2019. There are 12 older and no younger executives at Seneca Biopharma Inc. The oldest executive at Seneca Biopharma Inc is Stanley Westreich, 81, who is the Independent Director.

What's Binxian Wei's mailing address?

Binxian's mailing address filed with the SEC is 20271 GOLDENROD LANE, 2ND FLOOR, , GERMANTOWN, MD, 20876.

What does Seneca Biopharma Inc do?

Seneca Biopharma Inc executives and stock owners

Seneca Biopharma Inc executives and other stock owners filed with the SEC include:

• Dr. Kenneth C. Carter,
  Exec. Chairman & CEO
• Stanley Westreich,
  Independent Director
• Binxian Wei,
  Independent Director
• Sandford Smith,
  Independent Director
• Scott Ogilvie,
  Independent Director
• Cristina Csimma,
  Independent Director
• David Mazzo,
  Director
• Mary Gray,
  Director
• Dane Saglio,
  Chief Financial Officer, Principal Accounting Officer
• Matthew Kalnik,
  President, Chief Operating Officer
• Kenneth Carter,
  Executive Chairman, Principal Executive Officer
• Dr. David P. Recker FACR, M.D., FACP,
  Chief Medical Officer
• Dr. Thomas G. Hazel,
  Sr. VP of R&D
• Dr. Karl Y. Johe,
  Co-Founder